The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation
B. Borrego, C. Alonso, S. Moreno, N. de la Losa, P. J. Sanchez-Cordon, A. Brun
The paper evaluates the safety of the RVF vaccine candidate 40Fp8 in immunosuppressed mice, showing it is highly attenuated compared to other vaccine viruses.
bioRxiv · Feb 20, 2024Pathology